International Biotechnology Trust plc
Share this pagePrint this page

Portfolio Analysis

31 March 2016

Summary

 

IBT Portfolio NAV (m)

186

Number of Portfolio Companies

88

Quoted Investments

62

Unquoted Investments

26

 

NAV % Quoted / Unquoted Split
NAV % by Geography

Quoted

89%

United States / Canada

84%

Unquoted

11%

Europe

16%

Total

100% 

Total

100%

 

 

 

 

 

NAV % by Subsector
NAV % by Market Capitalisation

 

 

Therapeutics

86%

Large-Cap (>$10bn)

53%

Medical Devices

6%

Mid-Cap (>$1bn, <$10bn)

18%

Specialty Pharma

7%

Small-Cap (<$1bn)

17%

Life Sciences, Tools

1%

Unquoted

12%

 

NAV % by Portfolio Profitability
NAV % by Revenue Split

 

 

Profitable

67%

Revenue Generating

79%

Turning Profitable

5%

Near Revenue

2%

Unprofitable

28%

No Sales in the near term

19%

Total100%

Total

100%